Procter & Gamble Health Limited Share Price & Analysis
₹6,779.5▼ -1.07%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹6,779.5
-1.07%
Open
₹—
High
₹6,864.5
Low
₹6,740.5
Close
₹6,779.5
52W High
₹6,739
52W Low
₹4,707
Volume
5K
Lot Size
1
Sector
Healthcare
Market Cap
₹10K Cr
Face Value
—
Mid Cap
Price Chart
Fundamentals
P/E
30.6
Sector P/E
54.4
P/B
16.15
EPS
₹197.05
ROE
61.59%
ROCE
—
D/E Ratio
0.02
Div Yield
2.56%
Book Value
₹373.35
+
Strengths
- ✓Excellent return on equity (ROE 61.6%)
- ✓Attractively valued vs sector (P/E 30.6x vs industry 54.4x)
- ✓Virtually debt-free
- ✓Regular dividends — yield 2.6%
−
Concerns
- ✗High premium to book value (P/B 16.2x)
- ✗Trading near 52-week high (₹6,739)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
PGHL · as of Mar 2026
Promoters51.82%
FII6.86%▼0.15
DII14.21%▼0.50
Public27.11%▲0.64
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| FII | 7.60% | 6.24% | 6.39% | 6.61% | 7.01% | 6.86% |
| DII | 12.66% | 13.72% | 14.56% | 14.84% | 14.71% | 14.21% |
| Public | 27.92% | 28.22% | 27.24% | 26.74% | 26.47% | 27.11% |
Corporate Events
To consider and approve the financial results for the quarter ended Jun 30, 2026
Results5 Aug 2026
Dividend - Rs 45 Per Share
Dividend20 Aug 2026
Interim Dividend - Rs 110 Per Share & Special Dividend Rs 50 Per Share
Dividend11 Feb 2026
Dividend - Rs 45 Per Share
Dividend21 Aug 2025
Interim Dividend - Rs 80 Per Share
Dividend20 Feb 2025
Annual General Meeting/Dividend - Rs 60 Per Share
Dividend27 Nov 2024
Interim Dividend - Rs 50 Per Share & Special Dividend Rs 150 Per Share
Dividend13 Feb 2024
Annual General Meeting/Dividend - Rs 50 Per Share
Dividend22 Nov 2023
Latest News
All news →Related Analysis
Frequently Asked Questions
What is Procter & Gamble Health Limited share price today?▾
Procter & Gamble Health Limited (PGHL) is currently trading at ₹6,779.5 on NSE, down 1.07% as of the last market session. Prices update daily after market close on MarketNetra.
Is Procter & Gamble Health Limited available in F&O (Futures & Options)?▾
Yes, Procter & Gamble Health Limited (PGHL) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Procter & Gamble Health Limited 52-week high and low?▾
Procter & Gamble Health Limited's 52-week high is ₹6,739 and the 52-week low is ₹4,707. The current price of ₹6,779.5 is -0.6% below the 52W high.
What is Procter & Gamble Health Limited P/E ratio?▾
Procter & Gamble Health Limited's current P/E ratio is 30.6. This indicates the market is paying ₹30.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Procter & Gamble Health Limited options?▾
Procter & Gamble Health Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade PGHL options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.